본문 바로가기
KERD
논문KCI 등재

치매 및 우울증 고위험군 116례의 한의 치료에 대한 관찰 연구

Observational Study of the Treatment of 116 Cases of High Risk Group for Dementia and Depression in Multiple Korean Medicine Clinic

이재열|김용기|이동석|황지혜|하현이|장건|최중길|김면수|박준영|안영성
한의병리학회 (The Society of Pathology in Korean Medicine)|2021.06|동의생리병리학회지 (Journal of Physiology & Pathology in Korean Medicine)|제35권 제3호|pp. 104-116

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

DepressionDementiaTraditional Korean MedicineCognitive function
주제분류한의학

초록

In order to reduce the social and economic costs due to the increase in dementia patients, which is a representative senile disease in an aging society, it will be important to prevent dementia and to detect and treat early in high-risk groups. This study reported the results of treatment for the elderly with high risk of dementia and depression who received Korean medicine (KM) treatment in 9 KM clinics. Medical charts were surveyed on 116 patients with high risk of dementia and depression who received KM treatment at 9 KM clinics in Gangseo-gu from September 1, 2020 to December 31, 2020. The majority of the patients were female(76.72%), the average age was 71.66±7.18 years old, and the average education level was 8.96±3.91 years. The average treatment period was 61.47±10.30 days, the average number of treatments was 15.38±1.06 times, and both acupuncture and herbal medicine were administered. After receiving KM treatment, cognitive assessment scores such as MMSE-DS and MoCA-K, depression-related GDSSF-K score, dementia knowledge, attitude, and preventive behavior, blood debilitation scale, and GQOL-D score were improved compared to before. There was no specific adverse reaction except that one patient with elevated AST and ALT levels was observed. This study showed improvement in cognitive function, depression, dementia-related scale, and quality of life in high-risk groups for dementia and depression over 60 years old who received KM treatment. More systematic and large-scale planned clinical studies will be needed.

Abstract

In order to reduce the social and economic costs due to the increase in dementia patients, which is a representative senile disease in an aging society, it will be important to prevent dementia and to detect and treat early in high-risk groups. This study reported the results of treatment for the elderly with high risk of dementia and depression who received Korean medicine (KM) treatment in 9 KM clinics. Medical charts were surveyed on 116 patients with high risk of dementia and depression who received KM treatment at 9 KM clinics in Gangseo-gu from September 1, 2020 to December 31, 2020. The majority of the patients were female(76.72%), the average age was 71.66±7.18 years old, and the average education level was 8.96±3.91 years. The average treatment period was 61.47±10.30 days, the average number of treatments was 15.38±1.06 times, and both acupuncture and herbal medicine were administered. After receiving KM treatment, cognitive assessment scores such as MMSE-DS and MoCA-K, depression-related GDSSF-K score, dementia knowledge, attitude, and preventive behavior, blood debilitation scale, and GQOL-D score were improved compared to before. There was no specific adverse reaction except that one patient with elevated AST and ALT levels was observed. This study showed improvement in cognitive function, depression, dementia-related scale, and quality of life in high-risk groups for dementia and depression over 60 years old who received KM treatment. More systematic and large-scale planned clinical studies will be needed.

참고문헌 (44)

  1. "Korean Dementia observatory 2019" (2019)[URL]
  2. 박운제, "치매환자 특성의 추이 분석", 한국산학기술학회논문지, 18(1), pp.202~209 (2017), 한국산학기술학회[DOI]
  3. Relkin N, "Screening and early diagnosis of dementia", Am J Manag Care, 6(22), pp.S1111~8 (2000)
  4. Jorm AF, "Projections of future numbers of dementia cases in Australia with and without prevention", Aust N Z J Psychiatry, 39, pp.959~963 (2005)
  5. Final Report on development of a health promotion program for Korean medicine for the elderly, "Lee SD", ~ (2015)
  6. "OECD Health Policy Studies: Addressing Dementia: Improving the lives of people living with dementia" (2015)[URL]
  7. GKOM, "Korean Medicine Clinical Practice Guideline for Dementia", ~ (2017)
  8. Report on the results of the diagnosis of dementia by Korean medical method, "Kang HW", ~ (2014)
  9. The Korean Society of Oriental Neuropsychiatry Textbook Compilation Commmittee, "Oriental Neuropsychiatry", pp.333~342 (2010), Jipmoondang
  10. Choi Y, "Korean Traditional Medicine in Treating Patients with Mild Cognitive Impairment: a multicenter prospective observational case series", Evidence-Based Complementary and Alternative Medicine, 2020 (2020)
  11. Seoul metropolitan government, "2018 Elderly Korean Medicine Health Promotion Project Business Guide and Standard Manual", ~ (2018)
  12. Final report of the “Standardization of Dementia Diagnosis Tools” research project, "Kim GW", ~ (2009)
  13. Kee BS, "A preliminary study for the standardization of geriatric depression scale short form-Korea version", J Korean Neuropsychiatr Assoc, 35(2), pp.298~307 (1996)
  14. Final Report of the Dementia Prevalence Survey Project, "Jo MJ", ~ (2008)
  15. The Effect of Dementia Education on the Changes in Dementia Knowledge, Attitude, and Preventive Behavior of Middle-aged Low-Income Women, "Lee YW", Namgu Dementia Caring Center, ~ (2007)
  16. Jang SJ, "The Effect of Social Capital and Social Support on Behavioral Intention of Dementia Prevention : Regulation Effect of Family Strengths as the Cultural Characteristic of Korea", pp.2014
  17. 이고은, "한의학 병리적 노화 척도와 치매 한의학적 변증진단 개발 및 신뢰도 평가", 대한한의학회지, 38(3), pp.111~123 (2017), 대한한의학회[DOI]
  18. Hur J, "Donguibogam" (2007), Namsandang
  19. Lee JY, "Brief screening for mild cognitive impairment in elderly outpatient clinic : validation of the Korean version of the Montreal Cognitive Assessment", Journal of geriatric psychiatry and neurology, 21(2), pp.104~110 (2008)
  20. Lee HS, "The Standardization of the Ge riatric Quality of Life s cale-Dementia(GQOL-D)", Journal of the Korean Geriatrics Society, 8(3), pp.151~164 (2004)
  21. 오병훈, "치매의 행동•정신 증상 진단 및 관리", 대한의사협회지, 52(11), pp.1048~1054 (2009), 대한의사협회
  22. Morris JC, "Senile dementia of the Alzheimer's type : an important risk factor for serious falls", J Gerontol, 42, pp.412~417 (1987)
  23. Kim GB, "Current status and prospects of the elderly with dementia", The Korean Nurse, 37, pp.16~24 (1998)
  24. Kwon JD, "What to do with dementia?", Daejeon Branch of the Korean Dementia Family Association, ~ (2002)
  25. Rovner BW, "Depresion and Alzheimer's disease", American Journal of Psychiatry, 46, pp.350~353 (1989)
  26. Na YM, "Application and practice of horticultural therapy", pp.149~155 (1999), Seowon
  27. 정춘임, "요리 미술 활동이 치매 노인의 인지기능 및 우울에 미치는 효과", 대한한의진단학회지, 15(1), pp.67~76 (2011), 대한한의진단학회
  28. 강희철, "독거 여성 노인과 가족 동거 여성 노인의 양생 실천 수준과 불안, 우울, 인지기능에 대한 비교 연구", 동의신경정신과학회지, 25(2), pp.123~132 (2014), 대한한방신경정신과학회
  29. Chae KS, "Effects of the Laughing and Music Therapy on the Depression and Activities of Autonomic Nervous System for Elderly with Dementia", pp.2013
  30. 서은현, "치매 및 인지장애에서의 신경심리평가", 신경정신의학, 57(1), pp.2~11 (2018), 대한신경정신의학회[DOI]
  31. Yoo JE., "Recent changes and challenges in national dementia policy in Korea", Health Welf. Policy Forum, 276, pp.6~18 (2019)
  32. 김동희, "불면장애에 사용된 귀비탕의 동질성 연구 -CNKI에서 검색한 무작위배정 임상연구를 중심으로-", 동의신경정신과학회지, 29(3), pp.145~163 (2018), 대한한방신경정신과학회[DOI]
  33. Lee SH, "A Case Report of Patient with Psychogenic Tremor Treated with Gagamguibi-tang gamibang", The Journal of East-West Medicine, 41(3), pp.19~28 (2016)
  34. Kim JW, "The enhancing effects of Gwibi-tang(guipi-tang)on cognitive function and memory in scopolamine-induced dementia rat model", Oriental Rehabilitation Med, 22(3), pp.1~14 (2012)
  35. Tohda C, "Kihi-to, a herbal traditional medicine, improves Abeta(25–35)-induced memory impairment and losses of neurites and synapses", BMC Complementary and Alternative Medicine, 8(1), pp.1~21 (2008)
  36. Watari H, "Kihito, a traditional Japanese kampo medicine, improves cognitive function in Alzheimer’s disease patients", Evidence-Based Complementary and Alternative Medicine, 2019 (2019)
  37. Moon SY, "Comparative Effectiveness of Cheonwangbosimdan(Tian Wang Bu Xin Dan)Versus Cognitive-Behavioral Therapy for Insomnia in Cancer Patients : A Randomized, Controlled, Open-Label, Parallel-Group, Pilot Trial", Integrative Cancer Therapies, 19, pp.1534735420935643~ (2020)
  38. Elderly Korean Medicine Health Promotion Project Results Report, "Seoul metropolitan government", ~
  39. 2019 Elderly Korean Medicine Health Promotion Project Results Report, "Seoul metropolitan government", ~ (2019)
  40. 이미라, "중장년층의 치매에 대한 지식, 태도 및 예방행위", 디지털융복합연구, 17(12), pp.383~391 (2019), 한국디지털정책학회[DOI]
  41. 양지은, "乾癬으로 3개월 이상 한약을 복용한 환자 82명의 간수치 변화", 대한한의학회지, 33(3), pp.95~104 (2012), 대한한의학회
  42. 윤영주, "한약 복용이 간기능에 미치는 영향: 국내 문헌에 대한 체계적 고찰", 대한한방내과학회지, 30(1), pp.153~172 (2009), 대한한방내과학회
  43. 박영철, "독성학적 측면에서의 한약에 의한 간독성 유발과 기전", 대한한의학회지, 32(4), pp.48~67 (2011), 대한한의학회
  44. Jang IS, "A Review of Herbal Medicinal Products Associated with Toxic Events in Korea", J Korean Oriental Med, 28(1), pp.3~7 (2007)

관련 논문AI추천

지역사회 거주 경도인지장애 노인들을 대상으로 시행한한의치료의 보고: 인지기능을 중심으로김윤나, 배준상, 엄윤지, 윤현민, 이경석, 조성훈대한한방신경정신과학회 · 동의신경정신과학회지2019 · 제30권 제3호경도인지장애 환자의 장기간 한의약 치료 경과관찰 증례보고 2례강형원, 류영수, 손성은, 이고은, 이나현, 정문주대한한방신경정신과학회 · 동의신경정신과학회지2021 · 제32권 제3호치매의 한방치료와 한양방 협진치료에 관한 전문가 집단 설문연구강형원, 양현덕, 이고은, 전원경, 허은정대한한방신경정신과학회 · 동의신경정신과학회지2012 · 제23권 제4호한양방 협진치료를 받은 치매와 경도인지장애 환자에 대한 후향적 의무기록 분석강형원, 김남권, 김진원, 이고은, 이성익, 정문주대한한방신경정신과학회 · 동의신경정신과학회지2018 · 제29권 제2호노인성우울증에 대한 한방 집중치료 프로그램의 효과김가나, 조성훈, 황의완대한한방신경정신과학회 · 동의신경정신과학회지2014 · 제25권 제4호치매(痴呆)에 대한 임상 한의학 연구 경향 분석 : 지난 10년간의 국내 논문을 중심으로이동혁대한예방한의학회 · 대한예방한의학회지2020 · 제24권 제1호

이 간행물의 다른 논문 (2건)

골다공증의 한방 복합 처방 및 단일 본초에 대한 국내 연구 고찰- 2013년 이후 발표된 국내 연구를 중심으로이은정, 김남훈, 이정민pp. 87-96스코폴라민으로 유도한 기억력 손상 모델에서 소엽 추출물의 보호 효과박미희, 정은미, 김성규, 정지욱, 이은홍, 이지혜, 김동현pp. 97-103
원문 보기